
Symptoms of monkey pox can last for two to four weeks. These include fever, headache, skin rash and more.
Patients may receive extra fluids and treatment for secondary bacterial infections. An antiviral agent called tecovirimat (TPOXX) and manufactured by SIGA Technologies (SIGA.O) has been approved by international health authorities.
Another drug, called Tembexa and developed by Chimerix (CMRX.O), is also effective, according to experts.
Both TPOXX and Tembexa were approved based on animal studies. The data show that their effectiveness is high as vaccines helped eradicate smallpox in humans.
The WHO classified the disease as an extinct disease in 1980
There have been constant concerns that the virus could be used as a biological weapon. This will cause countries to accumulate quantities of vaccines.
The WHO holds 2.4 million doses at its Swiss headquarters dating back to the last years of the smallpox eradication program. The agency has also stated it will receive another 31 million from rich countries.
Experts in the US have said they have 1,000 doses of the Nordic-Bavarian vaccine in the national stock and expect that amount to increase. The country also has 100 million doses of ACAM2000.
Germany has said it had ordered 40,000 doses of the Bavarian Nordic vaccine, to be ready to vaccinate case contacts if needed.
Other countries, including Britain and France, are also offering vaccines to people in close contact with infected people and healthcare workers.
Bavarian Nordic, which has an annual production capacity of 30 million doses has stated that many countries are interested in getting the vaccine. A company spokesman said it would need to expand production.